BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6122288)

  • 1. Effects of the non-selective beta-adrenoceptor blocking agent, carteolol, on platelet function, blood coagulation and viscosity.
    Small M; Douglas JT; Aherne GW; Orr M; Lowe GD; Forbes CD; Prentice CR
    Thromb Res; 1982 Feb; 25(4):351-60. PubMed ID: 6122288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of alpha and beta receptor blocking agents with platelet release and availability reaction induced by ADP, adrenaline and collagen.
    Kubisz P; Caen J
    Pathol Biol (Paris); 1972 Dec; ():Suppl:34-40. PubMed ID: 4145190
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mechanisms of the thrombocytic effects of beta-adrenoblockaders].
    Tumasian KS; Akopov SE; Gabrielian ES
    Farmakol Toksikol; 1988; 51(5):49-53. PubMed ID: 2905276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the monobactam antibiotic aztreonam on platelet function and blood coagulation.
    Agnelli G; Guerciolini R; Grasselli S; Menichetti F; Pauluzzi S; Nenci GG; Del Favero A
    Chemotherapy; 1987; 33(1):9-14. PubMed ID: 2951237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of bupranolol, a new beta-blocker, on platelet functions of rabbit and human in vitro.
    Umetsu T; Sanai K; Kato T
    Thromb Haemost; 1976 Nov; 36(2):376-87. PubMed ID: 12593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective double-blind randomized study of the effects of four intravenous fluids on platelet function and hemostasis in elective hip surgery.
    Evans PA; Heptinstall S; Crowhurst EC; Davies T; Glenn JR; Madira W; Davidson SJ; Burman JF; Hoskinson J; Stray CM
    J Thromb Haemost; 2003 Oct; 1(10):2140-8. PubMed ID: 14521596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusaric acid, a mycotoxin, and its influence on blood coagulation and platelet function.
    Devaraja S; Girish KS; Santhosh MS; Hemshekhar M; Nayaka SC; Kemparaju K
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):419-23. PubMed ID: 23343693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian variation in platelet function in healthy volunteers.
    Jafri SM; VanRollins M; Ozawa T; Mammen EF; Goldberg AD; Goldstein S
    Am J Cardiol; 1992 Apr; 69(9):951-4. PubMed ID: 1532287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the new glycopeptide antibiotic teicoplanin on platelet function and blood coagulation.
    Agnelli G; Longetti M; Guerciolini R; Menichetti F; Grasselli S; Boldrini F; Bucaneve G; Nenci GG; Del Favero A
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1609-12. PubMed ID: 2963587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of somatostatin on coagulation and platelet function in man.
    Mielke CH; Gerich JE; Lorenzi M; Tsalikian E; Rodvien R; Forsham PH
    N Engl J Med; 1975 Sep; 293(10):480-3. PubMed ID: 1152862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of platelet beta-adrenoceptors for platelet responses in vivo and in vitro.
    Larsson PT; Wallén NH; Martinsson A; Egberg N; Hjemdahl P
    Thromb Haemost; 1992 Dec; 68(6):687-93. PubMed ID: 1337630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration-effect and time-effect relationships of carteolol.
    Ishizaki T; Ohnishi A; Sasaki T; Chiba K; Suganuma T; Kushida K
    Eur J Clin Pharmacol; 1983; 25(6):749-57. PubMed ID: 6141053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial agonist activity of carteolol on atypical beta-adrenoceptors in the guinea pig duodenum.
    Horinouchi T; Koike K
    Eur J Pharmacol; 2000 Sep; 403(1-2):133-8. PubMed ID: 10969154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the R(+)- and S(-)-isomers of beta-adrenoceptor blockers with intrinsic sympathomimetic activity, befunolol and carteolol, on rabbit intraocular pressure.
    Takayanagi I; Hagiwara H; Koike K; Hosokawa T; Kasuya Y
    Can J Physiol Pharmacol; 1991 Aug; 69(8):1243-5. PubMed ID: 1685941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of binding sites of CGP12177, a beta 3-adrenoceptor partial agonist, and carteolol, a beta 1/beta 2-adrenoceptor partial agonist, to the beta-adrenoceptors in guinea-pig taenia caecum.
    Koike K; Takayanagi I; Yamazaki M
    Can J Physiol Pharmacol; 1996 Aug; 74(8):928-33. PubMed ID: 8960382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of phentolamine, an alpha receptor blocking agent, on epinephrine, ADP and collagen induced factor 4 release and platelet aggregation.
    Kubisz P; Levy-Toledano S; Cronberg S; Pinkhas J; Caen J
    Rev Eur Etud Clin Biol; 1970 Apr; 15(4):429-32. PubMed ID: 4393725
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers.
    Gasser JA; Betterridge DJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S29-34. PubMed ID: 1721976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nebivolol on human platelet aggregation.
    Falciani M; Rinaldi B; D'Agostino B; Mazzeo F; Rossi S; Nobili B; Rossi F; Filippelli A
    J Cardiovasc Pharmacol; 2001 Dec; 38(6):922-9. PubMed ID: 11707696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further evidence that (+/-)-carteolol-induced relaxation is mediated by beta2-adrenoceptors but not by beta3-adrenoceptors in the guinea pig taenia caecum.
    Horinouchi T; Koike K
    J Smooth Muscle Res; 2000 Oct; 36(5):145-53. PubMed ID: 11286298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo platelet studies following oral nisoldipine in normotensive insulin-dependent diabetics and non-diabetic controls.
    Hendra TJ; Oughton J; Jeremy JY; Smith CC; Betteridge DJ; Dandona P; Yudkin JS
    Diabetes Res; 1988 Jul; 8(3):117-22. PubMed ID: 2976336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.